Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
SCHIZOPHRENIA POLICY ACTON NETWORK, INC. via MONUMENT ADVOCACY
2026 · third_quarter · Q3
Report on total cost of schizophrenia; access to treatment; issues related to serious mental illness; IMD exclusion; coordinated care, housing policy, and caregiver support
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)
NATIONAL COUNCIL FOR PRESCRIPTION DRUG PROGRAMS via MONUMENT ADVOCACY
2026 · third_quarter · Q3
Source: Senate LDA
Issues around electronic healthcare standards and interoperability, funding for standards development and integration, technology-based patient safety solutions.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
MCKESSON CORPORATION via MONUMENT ADVOCACY
2026 · third_quarter · Q3
ECAPS and Main Street Pharmacy Act; AI for clinical care; Protecting Patient Access to Cancer and Complex Therapies Act (Murphy)
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
INTEGRITY MARKETING GROUP via MONUMENT ADVOCACY
2026 · third_quarter · Q3
Issues related to insurance agent and broker fees in Medicare.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SCHIZOPHRENIA POLICY ACTON NETWORK, INC. via MONUMENT ADVOCACY
2026 · second_quarter · Q2
Appropriations for CDC funding for patient education and outreach; EPIC Act; report on total cost of schizophrenia; access to treatment; issues related to serious mental illness; IMD exclusion; coordinated care, housing policy, and caregiver support; Road to Housing bill
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL COUNCIL FOR PRESCRIPTION DRUG PROGRAMS via MONUMENT ADVOCACY
2026 · second_quarter · Q2
Issues around electronic healthcare standards and interoperability, funding for standards development and integration, technology-based patient safety solutions.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
MCKESSON CORPORATION via MONUMENT ADVOCACY
2026 · second_quarter · Q2
ECAPS and Main Street Pharmacy Act; AI for clinical care; Protecting Patient Access to Cancer and Complex Therapies Act (Murphy)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
INTEGRITY MARKETING GROUP via MONUMENT ADVOCACY
2026 · second_quarter · Q2
Issues related to insurance agent and broker fees in Medicare.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
ATHENAHEALTH, INC. via MONUMENT ADVOCACY
2026 · second_quarter · Q2
Issues related to health data exchange, interoperability, data standards, and Medicare Physician Fee Schedule.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
INTEGRITY MARKETING GROUP via MONUMENT ADVOCACY
2026 · first_quarter · Q1
Issues related to insurance agent and broker fees in Medicare.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
NATIONAL COUNCIL FOR PRESCRIPTION DRUG PROGRAMS via MONUMENT ADVOCACY
2026 · first_quarter · Q1
Issues around electronic healthcare standards and interoperability, funding for standards development and integration, technology-based patient safety solutions.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
MCKESSON CORPORATION via MONUMENT ADVOCACY
2026 · first_quarter · Q1
Issues around interoperability, data privacy and sharing in healthcare, drug shortages and healthcare transparency, 2026 rule and drug reimbursement changes.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ATHENAHEALTH, INC. via MONUMENT ADVOCACY
2026 · first_quarter · Q1
Issues related to health data exchange, interoperability, and data standards
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL COUNCIL FOR PRESCRIPTION DRUG PROGRAMS via MONUMENT ADVOCACY
2026 · first_quarter · RR
Issues around electronic healthcare standards and interoperability, funding for standards development and integration, technology-based patient safety solutions.
MCKESSON CORPORATION via MONUMENT ADVOCACY
2026 · first_quarter · RR
Issues around interoperability, data privacy and sharing in healthcare, drug shortages and healthcare transparency, 2026 rule and drug reimbursement changes.
INTEGRITY MARKETING GROUP via MONUMENT ADVOCACY
2026 · first_quarter · RR
Issues related to insurance agent and broker fees in Medicare.
ATHENAHEALTH, INC. via MONUMENT ADVOCACY
2026 · first_quarter · RR
Issues related to health data exchange, interoperability, and data standards.